-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$82.6289.41% Upside
Recent Analyst Forecasts and Stock Ratings
Legend Biotech Corporation Frequently Asked Questions
-
What analysts cover Legend Biotech Corporation?
Legend Biotech Corporation has been rated by research analysts at BTIG, Johnson Rice, Barclays, Redburn Partners, Piper Sandler, Truist Financial in the past 90 days.